Boston Scientific’s stock climbs on Q3 sales and earnings beat
Boston Scientific’s BSX net income was $469 million, or 32 cents a share, down from $505 million, or 34 cents a share, in the same period last year. On an adjusted basis, Boston Scientific reported earnings of 63 cents a share, above the FactSet consensus of 59 cents a share.
On Wednesday, Boston Scientific Corporation (NYSE:BSX) reported third-quarter revenues of $4.21 billion, beating the ...
William Plovanic, an analyst from Canaccord Genuity, maintained the Buy rating on Boston Scientific (BSX – Research Report). The ...
The med-tech company with approximately 9,400 employees in Minnesota posted profit and sales that beat Wall Street’s ...
21h
Good morning, Boston. Here are the five things you need to know in local business news to start your busy Thursday.
RBC Capital raised the firm’s price target on Boston Scientific (BSX) to $98 from $95 and keeps an Outperform rating on the shares. The ...
Boston Scientific's AVANT GUARD trial evaluates the FARAPULSE PFA System for treating persistent atrial fibrillation, pausing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback